News & Views
Laboratory scientists explore 'glowing' tumour detection
Apr 29 2010
Researchers at Vanderbilt University are using imaging agents in tumours that will cause specific parts to light up as they begin to form.
Fluorescent inhibitors of the enzyme cyclooxygenase-2 (COX-2) can be spotted at the pre-malignancy stage and may help to track the progress of the disease.
Commenting on the development, Dr Lawrence Marnett said he and his team are "very excited" and they are looking to perform human trials as soon as possible.
"It was a real challenge to make a compound that is COX-2 selective (doesn't bind to the related COX-1 enzyme), has desirable fluorescence properties and gets to the tissue in vivo," he explained.
Laboratory scientists recently revealed that twice as many Swedish people survive lung cancer than Brits with the disease.
According to the experts, a lack of awareness regarding the symptoms could be delaying treatment in the UK, leading to higher mortality rates.
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Nov 27 2024 Istanbul, Turkey
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE